aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Founded with a mission to innovate gene therapy, Rampart Bioscience develops advanced gene medicines aimed at providing long-lasting treatments for a variety of diseases. The company offers proprietary development and delivery platforms that create optimized therapeutics in a revocable, non-viral format. By integrating capabilities from gene delivery, protein sciences, and clinical translation, Rampart Bioscience focuses on assisting patients with genetically driven diseases.
Notable figures affiliated with Rampart Bioscience include leading scientists and experts in gene therapy and biotechnology. The company has attracted significant investment from prominent venture capital firms in the biotech sector. Key achievements include the development of groundbreaking gene therapy platforms that have shown promising results in preclinical studies. Rampart Bioscience's innovative approach has the potential to significantly impact the treatment landscape for genetic diseases, offering new hope to patients worldwide.
Operating Status
Active
Ownership Type(s)
Venture Capital
Main Product(s)
Gene Medicines
Technology
Biotech
Tags
Biotech
Model Types
Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
Global
When was Rampart Bioscience founded?
Rampart Bioscience was founded in 2019.
Where is Rampart Bioscience's headquarters located?
Rampart Bioscience's headquarters is located in Los Angeles, CA, US.
When was Rampart Bioscience's last funding round?
Rampart Bioscience's most recent funding round was for $85M (USD) in October 2023.
How many employees does Rampart Bioscience have?
Rampart Bioscience has 22 employees as of Feb 4, 2024.
How much has Rampart Bioscience raised to-date?
As of July 05, 2023, Rampart Bioscience has raised a total of $85M (USD) since Oct 24, 2023.
Add Comparison
Total Raised to Date
$85M
USD
Last Update Oct 24, 2023
Last Deal Details
$85M
USD
Oct 24, 2023
Series A
Total Employees Over Time
22
As of Feb 2024
Rampart Bioscience Address
Los Angeles,
California
95315
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts